Dissemination of extended-spectrum β-lactamase-producing bacteria: The food-borne outbreak lesson

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 6, 2008, Pages 1244-1251

  Lavilla, S ^a,b   Gonzalez Lopez J J ^a,b   Miro E ^c   Dominguez A ^d   Llagostera, M ^b   Bartolome R M ^a,b   Mirelis, B ^b,c   Navarro, F ^b,c   Prats, G ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Epidemiology; Food handling; Reservoir

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE CTX M 1; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 32; BETA LACTAMASE CTX M 9; BETA LACTAMASE SHV 12; BETA LACTAMASE SHV 2; BETA LACTAMASE TEM 52; EXTENDED SPECTRUM BETA LACTAMASE;

ACUTE GASTROENTERITIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE CARRIER; ENTEROPATHOGENIC ESCHERICHIA COLI; EPIDEMIC; FECES ANALYSIS; FOOD ANALYSIS; FOOD CONTAMINATION; FOOD HANDLING; HUMAN; MAJOR CLINICAL STUDY; SEROTYPING; SPAIN;

ANIMALS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; DISEASE OUTBREAKS; DISEASE RESERVOIRS; DISEASE TRANSMISSION, HORIZONTAL; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE; FECES; FOOD MICROBIOLOGY; FOOD POISONING; GASTROENTERITIS; HUMANS; MICROBIAL SENSITIVITY TESTS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEROTYPING; SPAIN;

EID: 44449169108     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn093     Document Type: Article

References (30)

1. Helfand MS, Bonomo RA. Extended-spectrum β-lactamases in multidrug-resistant Escherichia coli: Changing the therapy for hospital-acquired and community-acquired infections. Clin Infect Dis 2006; 43: 1415-6.
2. Jacoby GA, Munoz-Price LS. The new β-lactamases. N Engl J Med 2005; 352: 380-91.
3. Sturenbürg E, Mack D. Extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003; 47: 273-95.
4. Rodŕiguez-Baño J, Navarro MD, Romero L et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: A new clinical challenge. Clin Infect Dis 2006, 43: 1407-14.
5. Blanc V, Mesa R, Saco M et al. ESBL- and plasmidic class C β-lactamase-producing E. coli strains isolated from poultry, pig and rabbit farms. Vet Microbiol 2006; 118: 299-304.
6. Mesa RJ, Blanc V, Blanch AR et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J Antimicrob Chemother 2006; 58: 211-5.
7. Prats G, Mirelis B, Miró E et al. Cephalosoporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Emerg Infect Dis 2003; 9; 1273-80.
8. Johnson JR, Sannes MR, Croy C et al. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis 2007; 13: 838-46.
9. Collignon P, Aarestrup FM. Extended-spectrum β-lactamases, food, and cephalosporin use in food animals. Clin Infect Dis 2007; 44: 1391-2.
10. Jones TF, Schaffner W. New perspectives on the persistent scourge of foodborne disease. J Infect Dis 2005; 191: 1029-31.
11. Linton AH. Animal to man transmission of Enterobacteriaceae. R Soc Health J 1977; 97: 115-8.
12. Johnson JR, Kuskowski MA, Menard M et al. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis 2006; 194: 71-8.
13. Farmer JJ, III. Enterobacteriaceae: Introduction and identification. In: Murray PR, Baron EJ, Jorgensen JH et al., eds. Manual of Clinical Microbiology. Washington, DC: ASM Press, 2003; 636-53.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
15. Navarro F, Pérez-Trallero E, Marimón JM et al. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother 2001; 48: 383-9.
16. Sabaté M, Miró E, Navarro F et al. β-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J Antimicrob Chemother 2002; 49: 989-97.
17. Miró E, Mirelis B, Navarro F et al. Surveillance of extended-spectrum β-lactamasses from clinical samples and faecal carriers in Barcelona, Spain. J Antimicrob Chemother 2005; 56 1152-5.
18. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991; 19: 6823-31.
19. CTX-M-9 gene in non-related Escherichia coli from Barcelona. J Antimicrob Chemother 2005; 56: 819-26.
20. Blanco J, Blanco M, Alonso MP et al. Serogroups of Escherichia coli strains producing cytotoxic necrotizing factors CNF1 and CNF2. FEMS Microbiol Lett 1992; 75: 155-9.
21. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
22. Moreno E, Prats G, Sabaté M et al. Ouinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother 2006; 57: 204-11.
23. Johnson JR, Stell AL, O'Bryan TT et al. Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: Evidence of distribution beyond Europe. J Clin Microbiol 2002; 40: 1913-23.
24. Prats G, Navarro F, Mirelis B et al. Escherichia coli serotype O15:K52:H1 as a uropathogenic clone. J Clin Microbiol 2000; 38 201-9.
25. Manges AR, Johnson JR, Foxman B et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345: 1007-13.
26. Johnson JR, Murray AC, Kuskowski MA et al. Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis 2005; 11: 141-5.
27. Collignon P, Angulo FJ. Fluoroquinolone-resistant Escherichia coli food for thought. J Infect Dis 2006; 194: 8-10.
28. Peña C, Pujol M, Ardanuy C et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42: 53-8.
29. Pitout JD, Nordmann P, Laupland KB et al. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-9.
30. Snowdon J, Buzby J, Roberts T. Epidemiology, cost and risk of foodborne diseases. In: Cliver D, Rieman H, eds. Foodborne Diseases. Amsterdam: Academic Press, 2002; 31-51.